United States · Platforms & data · Yahoo Finance

The Call Bristol-Myers Squibb Bulls Got Right

Published by Yahoo Finance · United States 10 h ago

If you had been weighing Bristol-Myers Squibb against its looming patent cliffs and the promise of late-stage oncology drugs back in October 2025, the result now looks very…

Read the full article on Yahoo Finance Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

MarketBeat

FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds

The Motley Fool

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

TheStreet

The Call Bristol-Myers Squibb Bulls Got Right

Share

Also worth reading

FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds

Should Investors Buy the Meta Platforms Dip?

Trump announces Audi will build $4 billion US factory in Georgia

Musk says Ukraine violated Starlink terms with offensive drone strikes

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Gold prices break $4,000 as investors brace for crucial test